BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 16943567)

  • 1. Quantitative real-time RT-PCR of disseminated tumor cells in combination with immunomagnetic cell enrichment.
    Lankiewicz S; Rivero BG; Bócher O
    Mol Biotechnol; 2006 Sep; 34(1):15-27. PubMed ID: 16943567
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Optimisation of the RT-PCR detection of immunomagnetically enriched carcinoma cells.
    Raynor M; Stephenson SA; Walsh DC; Pittman KB; Dobrovic A
    BMC Cancer; 2002 May; 2():14. PubMed ID: 12031094
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monitoring of tumor cell purging after highly efficient immunomagnetic selection of CD34 cells from leukapheresis products in breast cancer patients: comparison of immunocytochemical tumor cell staining and reverse transcriptase-polymerase chain reaction.
    Mapara MY; Körner IJ; Hildebrandt M; Bargou R; Krahl D; Reichardt P; Dörken B
    Blood; 1997 Jan; 89(1):337-44. PubMed ID: 8978310
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sensitive detection of micrometastases in bone marrow from patients with breast cancer using immunomagnetic isolation of tumor cells in combination with reverse transcriptase/polymerase chain reaction for cytokeratin-19.
    Zhong XY; Kaul S; Lin YS; Eichler A; Bastert G
    J Cancer Res Clin Oncol; 2000 Apr; 126(4):212-8. PubMed ID: 10782894
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of circulating tumor cells in breast cancer with a refined immunomagnetic nanoparticle enriched assay and nested-RT-PCR.
    Li FR; Li Q; Zhou HX; Qi H; Deng CY
    Nanomedicine; 2013 Oct; 9(7):1106-13. PubMed ID: 23506951
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Application of immunomagnetic cell enrichment in combination with RT-PCR for the detection of rare circulating head and neck tumor cells in human peripheral blood.
    Tong X; Yang L; Lang JC; Zborowski M; Chalmers JJ
    Cytometry B Clin Cytom; 2007 Sep; 72(5):310-23. PubMed ID: 17205568
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of germ-cell-tumor-specific gene products in peripheral blood by immunomagnetic tumor cell enrichment followed by RT-PCR.
    Schrader M; Weissbach L; Müller M; Straub B; Krause H; Goessl C; Schostak M; Rittner HL; Stange S; Miller K
    Int J Mol Med; 2004 May; 13(5):685-90. PubMed ID: 15067371
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combination of immunomagnetic enrichment with multiplex RT-PCR analysis for the detection of disseminated tumor cells.
    Zieglschmid V; Hollmann C; Gutierrez B; Albert W; Strothoff D; Gross E; Böcher O
    Anticancer Res; 2005; 25(3A):1803-10. PubMed ID: 16033103
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Specific isolation of disseminated cancer cells: a new method permitting sensitive detection of target molecules of diagnostic and therapeutic value.
    Tveito S; Maelandsmo GM; Hoifodt HK; Rasmussen H; Fodstad O
    Clin Exp Metastasis; 2007; 24(5):317-27. PubMed ID: 17530423
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of cytokeratin 20 mRNA in the peripheral blood of patients with colorectal cancer by immunomagnetic bead enrichment and real-time reverse transcriptase-polymeras chain reaction.
    Guo J; Xiao B; Jin Z; Qin L; Chen J; Chen H; Zhang X; Liu Z
    J Gastroenterol Hepatol; 2005 Aug; 20(8):1279-84. PubMed ID: 16048578
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Maspin and mammaglobin genes are specific markers for RT-PCR detection of minimal residual disease in patients with breast cancer.
    Corradini P; Voena C; Astolfi M; Delloro S; Pilotti S; Arrigoni G; Bregni M; Pileri A; Gianni AM
    Ann Oncol; 2001 Dec; 12(12):1693-8. PubMed ID: 11843246
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of EpCAM positive cells isolated from sentinel lymph nodes of breast cancer patients identifies subpopulations of cells with distinct transcription profiles.
    Tveito S; Andersen K; Kåresen R; Fodstad Ø
    Breast Cancer Res; 2011 Aug; 13(4):R75. PubMed ID: 21816090
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Real-time RT-PCR correlates with immunocytochemistry for the detection of disseminated epithelial cells in bone marrow aspirates of patients with breast cancer.
    Benoy IH; Elst H; Van der Auwera I; Van Laere S; van Dam P; Van Marck E; Scharpé S; Vermeulen PB; Dirix LY
    Br J Cancer; 2004 Nov; 91(10):1813-20. PubMed ID: 15505629
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunomagnetic CD45 depletion does not improve cytokeratin 20 RT-PCR in colorectal cancer.
    Ausch C; Dandachi N; Buxhofer-Ausch V; Balic M; Huber K; Bauernhofer T; Ogris E; Hinterberger W; Braun S; Schiessel R
    Clin Chem Lab Med; 2007; 45(3):351-6. PubMed ID: 17378731
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of circulating tumour cells in early stage breast cancer patients using multi marker immunobead RT-PCR.
    Raynor MP; Stephenson SA; Pittman KB; Walsh DC; Henderson MA; Dobrovic A
    J Hematol Oncol; 2009 Jun; 2():24. PubMed ID: 19500345
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of HER2 status in breast cancer: comparison of current methods with MLPA and real-time RT-PCR.
    Pazhoomand R; Keyhani E; Banan M; Najmabadi H; Khodadadi F; Iraniparast A; Feiz F; Majidzadeh K; Bahman I; Moghadam FA; Sobhani AM; Muhammadnejad A; Abedini SS; Behjati F
    Asian Pac J Cancer Prev; 2013; 14(12):7621-8. PubMed ID: 24460343
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of micrometastatic breast cancer by means of real time quantitative RT-PCR and immunostaining in perioperative blood samples and sentinel nodes.
    Schröder CP; Ruiters MHJ; de Jong S; Tiebosch ATMG; Wesseling J; Veenstra R; de Vries J; Hoekstra HJ; de Leij LFMH; de Vries EGE
    Int J Cancer; 2003 Sep; 106(4):611-618. PubMed ID: 12845661
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of micrometastases in peripheral blood of non-small cell lung cancer with a refined immunomagnetic nanoparticle enrichment assay.
    Li Q; Qi H; Zhou HX; Deng CY; Zhu H; Li JF; Wang XL; Li FR
    Int J Nanomedicine; 2011; 6():2175-81. PubMed ID: 22114481
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of tumor cell-specific mRNA in the peripheral blood of patients with breast cancer—evaluation of several markers with real-time reverse transcription-PCR.
    Andergassen U; Hofmann S; Kölbl AC; Schindlbeck C; Neugebauer J; Hutter S; Engelstädter V; Ilmer M; Friese K; Jeschke U
    Int J Mol Sci; 2013 Jan; 14(1):1093-104. PubMed ID: 23299436
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mammaglobin as a novel breast cancer biomarker: multigene reverse transcription-PCR assay and sandwich ELISA.
    Zehentner BK; Persing DH; Deme A; Toure P; Hawes SE; Brooks L; Feng Q; Hayes DC; Critichlow CW; Houghton RL; Kiviat NB
    Clin Chem; 2004 Nov; 50(11):2069-76. PubMed ID: 15375015
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.